FDA.reportPublic FDA data

CLINDAMYCIN 1% / NIACINAMIDE 4%

Manufacturer
Sincerus Florida, LLC
Effective date
2019-08-19
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:29:27

Label at a glance#

ProductCLINDAMYCIN 1% / NIACINAMIDE 4%
Active ingredientNIACINAMIDE, CLINDAMYCIN PHOSPHATE
Label structure4 sections

Label contents#

Full prescribing information#

Directions for use

INSTRUCTIONS FOR USE SECTION

dsds

Sincerus Florida, LLC. Adverse reactions

ADVERSE REACTIONS SECTION

XX

Active, inactive

COMPONENTS

SASSAS

NDC 72934- 1051-2 CLINDAMYCIN PHOSPHATE USP 1% / NIACINAMIDE USP 4%. Gel 30gm

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

zczc

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CLINDAMYCIN Pharmacologic Class Indexing3Indexing - Pharmacologic Class20210811

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
1426d8f8-b7d5-4053-8554-613df00c0d86Product name220250616
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
d8f81258-db12-0761-46cc-8ff6e62e9302Product name420240422
b7b2fa42-1c77-d724-81f0-87da60a77e79Product name320240320
b27c7c65-51f2-a62f-e0e6-a26b3a0f8eb0Product name320230425
e3af9708-3004-7392-4046-5311eaa8bab5Product name320221128
ffb4bacf-f636-0f7d-0b0d-7a4b151243e3Product name920220928
b72227d6-0388-43bd-995b-b762d2754cd5Product name120220706
a92d22e0-3af4-f301-bc88-27ff030b0070Product name220220316
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
5ce6ce33-4f2b-3ce0-757d-e520013280cfProduct name520180719
b92a26f1-6926-4817-be73-e26ab4c2146fProduct name120170602
028d6c95-5012-6976-2075-dee0ae6fefe2Product name120140508
468b2c08-8adb-8d0f-8257-c6515a061424Product name120140508
8959fb29-d86f-c521-666a-b4cb22233594Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72934-1051-22021-01-29C16284748780-1ba0f9c33-5183-a910-e053-dadaa90a0b85CLINDAMYCIN 1% / NIACINAMIDE 4%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72934-1051-2CLINDAMYCIN 1% / NIACINAMIDE 4%30 g in 1 BOTTLE, PUMPGEL302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72934-1051CLINDAMYCIN 1% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC]2Legacy NDC, 1 package rows20190820_88786626-1999-7791-e053-2a95a90a91f6.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72934-1051-2GM - Gram72934-10514c2386e5-f364-40dc-b8a2-5c756111a8cc12020-02-13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72934-105172934-1051-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
NIACINAMIDE25X51I8RD4ACTIB
CLINDAMYCIN PHOSPHATEEH6D7113I8ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
907a0ee6-b91e-58fe-e053-2a95a90a0cb888786626-1999-7791-e053-2a95a90a91f62019-08-19Adverse reactionsExact identifier
spl id: 907a0ee6-b91e-58fe-e053-2a95a90a0cb8
spl set id: 88786626-1999-7791-e053-2a95a90a91f6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.